CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function
NACompletedINTERVENTIONAL
Enrollment
3
Participants
Timeline
Start Date
May 31, 2014
Primary Completion Date
July 31, 2019
Study Completion Date
March 31, 2023
Conditions
Malignant DiseasesNon-malignant Diseases
Interventions
DEVICE
CliniMACS CD34+ cell enrichment and T-cell depletion
Trial Locations (1)
94305
Stanford Children's Hospital, Palo Alto
All Listed Sponsors
lead
Rajni Agarwal
OTHER
NCT02162511 - CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function | Biotech Hunter | Biotech Hunter